HPS wins contract to supply over labelled medicines to a group of NHS Trusts
HPS are delighted to announce the securing of significant medicines over labelling business from a consortium of NHS Trusts.
- HPS TO PACKAGE, LABEL AND DISTRIBUTE IMPS FOR THE ABC-12 TRIAL
- HPS CONTRACTED TO DEVELOP NEW IMPS FOR THE MND SMART TRIAL, 2023
- HPS to manufacture medicines for cystic fibrosis clinical trial
- HPS supply crucial over labelled medicines to COVID19 hub
- HPS win contract to manufacture medicinal product to help combat the spread of COVID19 infection
- HPS TO PACKAGE, LABEL AND DISTRIBUTE IMPS FOR THE ABC-12 TRIAL
- HPS CONTRACTED TO DEVELOP NEW IMPS FOR THE MND SMART TRIAL, 2023
- HPS to manufacture medicines for cystic fibrosis clinical trial
- HPS supply crucial over labelled medicines to COVID19 hub
- HPS win contract to manufacture medicinal product to help combat the spread of COVID19 infection
- HPS TO PACKAGE, LABEL AND DISTRIBUTE IMPS FOR THE ABC-12 TRIAL
- HPS CONTRACTED TO DEVELOP NEW IMPS FOR THE MND SMART TRIAL, 2023
- HPS to manufacture medicines for cystic fibrosis clinical trial
- HPS supply crucial over labelled medicines to COVID19 hub
- HPS win contract to manufacture medicinal product to help combat the spread of COVID19 infection
